Speaker Profile

___	__
	Biography Lei Fu is a clinical biochemist, in the Precision Diagnostics and Therapeutics Program, at the Sunnybrook Health Sciences Centre, and assistant professor at the Department of Laboratory Medicine and Pathobiology, University of Toronto. She completed her training at the McMaster Clinical Chemistry Postdoctoral Fellowship Program. She was certified by the Canadian Academy of Clinical Biochemistry, and certified by the American Board of Clinical Biochemistry in all three disciplines, Clinical Chemistry, Toxicological Chemistry, and Molecular Diagnostics. She is actively engaged in clinical service, teaching, and research. Her research interests are in two areas, biomarkers in maternal and fetal health, and clinical applications of pharmacogenetics. Disclosure 1. I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose. 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).

Biography
Lei Fu is a clinical biochemist, in the Precision Diagnostics and Therapeutics Program, at the Sunnybrook Health Sciences Centre, and assistant professor at the Department of Laboratory Medicine and Pathobiology, University of Toronto. She completed her training at the McMaster Clinical Chemistry Postdoctoral Fellowship Program. She was certified by the Canadian Academy of Clinical Biochemistry, and certified by the American Board of Clinical Biochemistry in all three disciplines, Clinical Chemistry, Toxicological Chemistry, and Molecular Diagnostics. She is actively engaged in clinical service, teaching, and research. Her research interests are in two areas, biomarkers in maternal and fetal health, and clinical applications of pharmacogenetics.
Disclosure
1. I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose. 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).